Online exclusiveTransitioning Florida NPs to opioid prescribingCraig-Rodriguez, Alicia DNP, MBA, FNP-BC; Gordon, Glenna MS; Kaplan, Louise PhD, ARNP, FNP-BC, FAANP, FAAN; Grubbs, Laurie PhD, ARNPAuthor Information Alicia Craig-Rodriguez is an associate faculty at Florida State University, College of Nursing, Tallahassee, Fla. Glenna Gordon is an assistant in research at Florida State University, College of Nursing, Tallahassee, Fla. Louise Kaplan is an associate professor at Washington State University Vancouver, Vancouver, Wash. Laurie Grubbs is a professor at Florida State University, College of Nursing, Tallahassee, Fla. The authors would like to thank Dr. Susan Porterfield, Dr. Kimberly Hires, Dr. Geraldine Martorella, and Jamie Marsh for their support during this study. The authors have disclosed that they have no financial relationships related to this article. The Nurse Practitioner: September 21, 2017 - Volume 42 - Issue 9 - p 1-8 doi: 10.1097/01.NPR.0000521997.84052.ef Buy Metrics Abstract Prior to statutory changes in prescriptive authority for controlled substances, this study examined the knowledge gaps and prescribing limitations of Florida advanced registered nurse practitioners regarding opioids. Study results revealed statistically significant knowledge gaps in the areas of federal and state guidelines; opioid classes and proper doses; risk assessment skills; monitoring of treatment; and confidence in dealing with challenges of opioid prescribing. Wolters Kluwer Health, Inc. All rights reserved.